A new small device is paving the way for big changes in diabetes management.

First company to enable precision in vivo genome engineering, combining both cell-specific delivery and programmable, locus-specific gene insertion, with the potential to achieve physiological, durabl ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Improvements in sensitivity, specificity, and accurate quantitation allow researchers to glean valuable information from hundreds of samples in record time.

The group of lifelong intestinal conditions known as inflammatory bowel disease (IBD), which includes Crohn's disease and ...

A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research Institute of A Coruña ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Dr. Tony Ye Hu resigned from Tulane University to accept the position of dean of the school of biomedical engineering at ...